588 related articles for article (PubMed ID: 28270230)
1. Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review.
Mitchell R; Barton S; Harvey AS; Williams K
Syst Rev; 2017 Mar; 6(1):49. PubMed ID: 28270230
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta-analysis.
Mitchell RA; Barton SM; Harvey AS; Ure AM; Williams K
Dev Med Child Neurol; 2021 Jul; 63(7):791-801. PubMed ID: 33432576
[TBL] [Abstract][Full Text] [Related]
3. The autism spectrum disorder phenotype in children with tuberous sclerosis complex: A systematic review and meta-analysis.
Mitchell RA; Mitchell M; Williams K
Dev Med Child Neurol; 2022 Oct; 64(10):1214-1229. PubMed ID: 35724267
[TBL] [Abstract][Full Text] [Related]
4. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
[TBL] [Abstract][Full Text] [Related]
5. Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.
Vignoli A; La Briola F; Peron A; Turner K; Vannicola C; Saccani M; Magnaghi E; Scornavacca GF; Canevini MP
Orphanet J Rare Dis; 2015 Dec; 10():154. PubMed ID: 26631248
[TBL] [Abstract][Full Text] [Related]
6. Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder.
Prohl AK; Scherrer B; Tomas-Fernandez X; Davis PE; Filip-Dhima R; Prabhu SP; Peters JM; Bebin EM; Krueger DA; Northrup H; Wu JY; Sahin M; Warfield SK;
J Neurodev Disord; 2019 Dec; 11(1):36. PubMed ID: 31838998
[TBL] [Abstract][Full Text] [Related]
7. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations.
Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401
[TBL] [Abstract][Full Text] [Related]
8. Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
Catalá-López F; Hutton B; Page MJ; Ridao M; Driver JA; Alonso-Arroyo A; Forés-Martos J; Macías Saint-Gerons D; Vieta E; Valencia A; Tabarés-Seisdedos R
Syst Rev; 2017 Sep; 6(1):189. PubMed ID: 28915839
[TBL] [Abstract][Full Text] [Related]
9. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.
Numis AL; Major P; Montenegro MA; Muzykewicz DA; Pulsifer MB; Thiele EA
Neurology; 2011 Mar; 76(11):981-7. PubMed ID: 21403110
[TBL] [Abstract][Full Text] [Related]
10. Autism and Epilepsy in Patients With Tuberous Sclerosis Complex.
Specchio N; Pietrafusa N; Trivisano M; Moavero R; De Palma L; Ferretti A; Vigevano F; Curatolo P
Front Neurol; 2020; 11():639. PubMed ID: 32849171
[No Abstract] [Full Text] [Related]
11. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study.
Gupta A; de Bruyn G; Tousseyn S; Krishnan B; Lagae L; Agarwal N;
Pediatr Neurol; 2020 May; 106():10-16. PubMed ID: 32139167
[TBL] [Abstract][Full Text] [Related]
13. The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex.
Huang CH; Peng SS; Weng WC; Su YN; Lee WT;
J Formos Med Assoc; 2015 Sep; 114(9):849-54. PubMed ID: 24698169
[TBL] [Abstract][Full Text] [Related]
14. New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).
Gipson TT; Johnston MV
F1000Res; 2017; 6():. PubMed ID: 28663780
[TBL] [Abstract][Full Text] [Related]
15. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
16. Significance of tuber size for complications of tuberous sclerosis complex.
Pascual-Castroviejo I; Hernández-Moneo JL; Pascual-Pascual SI; Viaño J; Gutiérrez-Molina M; Velazquez-Fragua R; Quiñones Tapia D; Morales Bastos C
Neurologia; 2013; 28(9):550-7. PubMed ID: 23274119
[TBL] [Abstract][Full Text] [Related]
17. Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.
Mühlebner A; van Scheppingen J; de Neef A; Bongaarts A; Zimmer TS; Mills JD; Jansen FE; Spliet WGM; Krsek P; Zamecnik J; Coras R; Blumcke I; Feucht M; Scholl T; Gruber VE; Hainfellner JA; Söylemezoğlu F; Kotulska K; Lagae L; Jansen AC; Kwiatkowski DJ; Jozwiak S; Curatolo P; Aronica E
J Neuropathol Exp Neurol; 2020 Oct; 79(10):1054-1064. PubMed ID: 32954437
[TBL] [Abstract][Full Text] [Related]
18. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
Kothare SV; Singh K; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1025-9. PubMed ID: 24917535
[TBL] [Abstract][Full Text] [Related]
19. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
20. Genotype/Phenotype Correlations in Tuberous Sclerosis Complex.
Curatolo P; Moavero R; Roberto D; Graziola F
Semin Pediatr Neurol; 2015 Dec; 22(4):259-73. PubMed ID: 26706013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
